CareMax, Inc. Schedules First Quarter 2023 Earnings Conference Call
CareMax, Inc. (NASDAQ: CMAX; CMAXW) announced it will release its first quarter 2023 financial results on May 10, 2023, before market opening. The company will host a conference call at 8:30 AM ET the same day to discuss these results. Participants can join via phone or through a live audio webcast, available on CareMax’s investor relations website. Established in 2011, CareMax delivers value-based care to seniors through a proprietary technology platform and multi-specialty health model, operating over 2,000 employed and affiliated providers in 10 states. The firm aims to enhance healthcare quality while reducing costs and promoting equity for senior populations.
- None.
- None.
The conference call can be accessed by dialing (888) 330-2508 for
About
Founded in 2011,
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, strategy and financial performance, the closing of the Steward transaction and the benefits thereof, and the filing of the Company’s periodic reports. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the Company’s ability to integrate acquired businesses, including the ability to implement business plans, forecasts, and other expectations after the completion of the Steward transaction, the failure to realize anticipated benefits of the Steward transaction or to realize estimated pro forma results and underlying assumptions,, the impact of COVID-19 or any variant thereof on the Company's business and results of operation; the availability of sites for de novo centers and the costs of opening such de novo centers; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage and Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; any delay, modification or cancellation of government contracts; the Company's future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs and the Company’s ability to comply with the covenants under its credit agreement; the Company's ability to recruit and retain qualified team members and independent physicians; and risks related to future acquisitions. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230510005002/en/
Investor Relations
VP Investor Relations
(847) 924-8980
samantha.swerdlin@caremax.com
Media
(305) 542-8855
christine@thinkbsg.com
Source:
FAQ
When will CareMax release its Q1 2023 financial results?
What time is the CareMax conference call scheduled for?
How can I access the CareMax Q1 2023 financial results call?